Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
NCT02795780 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2020-08-24
Summary
This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.
Conditions
Interventions
- DRUG
-
Flortaucipir F18
370 megabecquerel (MBq) IV single-dose
- PROCEDURE
-
PET Scan
positron emission tomography (PET) scan
Sponsors & Collaborators
-
Avid Radiopharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2017-08-28
- Completion
- 2017-08-28
Countries
- United States
Study Locations
More Related Trials
-
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
NCT02676843 ·Status: COMPLETED ·Phase: PHASE2
-
Tau Screening Study in Patients With Early Symptomatic AD
NCT03322462 ·Status: COMPLETED ·Phase: PHASE2
-
F 18 T807 Tau PET Imaging of Alzheimer's Disease
NCT02414347 ·Status: RECRUITING
-
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
NCT02167594 ·Status: COMPLETED ·Phase: PHASE1
-
Tau PET Imaging in the NACC Study Cohort
NCT03189485 ·Status: ACTIVE_NOT_RECRUITING
-
Imaging Tau Deposition in the Brain of Elderly Subjects
NCT02958670 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET Tau - Neurodegenerative Disease Imaging
NCT03143374 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07
NCT01447719 ·Status: COMPLETED ·Phase: PHASE3
-
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
NCT02850146 ·Status: COMPLETED ·Phase: PHASE1
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
NCT04926259 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Tau PET Imaging in Atypical Dementias
NCT03283449 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
NCT05456503 ·Status: RECRUITING ·Phase: PHASE3
-
Imaging Tau in Alzheimer's Disease and Normal Aging
NCT03373604 ·Status: COMPLETED ·Phase: PHASE2
-
Tau PET Outcomes With Anti-amyloid Immunotherapies
NCT06723015 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150 ·Status: UNKNOWN ·Phase: PHASE2
-
F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)
NCT02707978 ·Status: WITHDRAWN ·Phase: PHASE2
-
Tau Imaging in Young Onset Dementia
NCT02289118 ·Status: COMPLETED
-
18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
NCT02556502 ·Status: COMPLETED ·Phase: NA
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894 ·Status: COMPLETED ·Phase: PHASE1
-
18F-AV-1451 PET Imaging in TBI
NCT02512029 ·Status: WITHDRAWN ·Phase: PHASE1
-
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
NCT05658913 ·Status: RECRUITING
-
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
NCT02370524 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
NCT01733355 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)
NCT02414282 ·Status: COMPLETED